Table 3

Prevalence of chronic kidney disease stages 3–5 (eGFR <60 mL/min per 1.73 m2) in various age groups and according to gender based on different estimating equations
Marker Age group Men Women Total
N (%) N (%) N (%)
MDRD 65–69 26 (14.5) 50 (29.1) 76 (21.7)
70–79 101 (27.5) 105 (34.4) 206 (30.6)
80+ 128 (44.3) 94 (59.5) 222 (49.7)
Overall 255 (30.5) 249 (39.2) 504 (34.3)
CKD-EPI 65–69 21 (11.7) 34 (19.8) 55 (15.7)
70–79 98 (26.6) 90 (29.5) 188 (27.9)
80+ 146 (50.5) 97 (61.4) 243 (54.4)
Overall 265 (31.7) 221 (34.8) 486 (33.0)
Cystatin-C based eGFR 65–69 4 (2.2) 7 (4.1) 11 (3.1)
70–79 30 (8.2) 36 (11.8) 66 (9.8)
80+ 86 (29.8) 51 (32.3) 137 (30.7)
Overall 120 (14.4) 94 (14.8) 214 (14.6)
Albumin creatinine ratio (ACR) > 30 mg/g 65–69 17 (9.5) 7 (4.1) 24 (6.8)
70–79 43 (11.7) 12 (3.9) 55 (8.2)
80+ 49 (17.0) 17 (10.8) 66 (14.8)
Overall 109 (13.0) 36 (5.7) 145 (9.9)

Rothenbacher et al.

Rothenbacher et al. BMC Public Health 2012 12:343   doi:10.1186/1471-2458-12-343

Open Data